Admetsys’ Glycemic Control System Grabs CE Mark
Admetsys has received CE mark certification for its PrecisionOne system, a device that provides automated glucose control and real-time blood chemistry analyses for critical care patients.
The automated system enables hospitals to provide “safer, more effective care that can scale to meet peak demand, with less manual intervention by clinicians,” the company said. “This is a key element of COVID-19 response and a fundamental factor in hospital preparedness for future public health needs.”
The PrecisionOne system is the first fully automated glycemic system and continuous diagnostic platform for hospital care, Admetsys said.